OC
TRHC

Oppenheimer & Co’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Oppenheimer & Co’s Portfolio TRHC Stock Details TRHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,968
Closed -$107K – 1488
2023
Q2 		$107K Sell
12,968
-3,452
-21% -$20.7K ﹤0.01% 1352
2023
Q1 		$91.8K Sell
16,420
-2,034
-11% -$11.6K ﹤0.01% 1325
2022
Q4 		$91.3K Sell
18,454
-10,862
-37% -$44.8K ﹤0.01% 1296
2022
Q3 		$141K Sell
29,316
-559
-2% -$2.4K ﹤0.01% 1266
2022
Q2 		$77K Sell
29,875
-144
-0.5% -$540 ﹤0.01% 1352
2022
Q1 		$173K Buy
30,019
+740
+3% +$6.64K ﹤0.01% 1373
2021
Q4 		$439K Sell
29,279
-17,960
-38% -$327K 0.01% 1093
2021
Q3 		$1.24M Buy
47,239
+4,047
+9% +$149K 0.02% 666
2021
Q2 		$2.16M Sell
43,192
-86
-0.2% -$3.85K 0.04% 493
2021
Q1 		$1.99M Sell
43,278
-18,964
-30% -$905K 0.04% 473
2020
Q4 		$2.67M Buy
62,242
+20,724
+50% +$787K 0.06% 369
2020
Q3 		$1.69M Buy
41,518
+158
+0.4% +$7.87K 0.04% 428
2020
Q2 		$2.26M Sell
41,360
-623
-1% -$35.6K 0.06% 345
2020
Q1 		$2.19M Sell
41,983
-5,711
-12% -$309K 0.07% 320
2019
Q4 		$2.32M Buy
47,694
+10,323
+28% +$483K 0.06% 370
2019
Q3 		$2.05M Buy
37,371
+8,360
+29% +$478K 0.06% 386
2019
Q2 		$1.45M Buy
29,011
+14,237
+96% +$708K 0.04% 486
2019
Q1 		$834K Buy
14,774
+9,898
+203% +$590K 0.02% 637
2018
Q4 		$311K Buy
4,876
+42
+0.9% +$2.97K 0.01% 912
2018
Q3 		$392K Sell
4,834
-415
-8% -$30.4K 0.01% 957
2018
Q2 		$335K Buy
+5,249
New +$257K 0.01% 1015

Other funds holding TRHC

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
BSCM
Berry Street Capital Management London, United Kingdom $340M AUM 65.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Oppenheimer & Co's TRHC Position: Q3 2023 in Review

Oppenheimer & Co sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q3 2023, closing a stake of 12,968 shares — an estimated $107K sold.

Oppenheimer & Co first reported a position in TRHC in Q2 2018 and held it in 21 quarters. The position peaked at $2.67M in Q4 2020. 84 funds tracked by Wall St. Rank hold TRHC as of Q3 2023.

  • Oppenheimer & Co reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Oppenheimer & Co sold 12,968 Tabula Rasa HealthCare, Inc. Common Stock shares in Q3 2023, an estimated $107K.
  • Oppenheimer & Co first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q2 2018 and held it in 21 quarters.
  • Oppenheimer & Co's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $2.67M in Q4 2020.
  • 84 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q3 2023.

Based on Oppenheimer & Co's 13F filing for Q3 2023, filed 8 Nov 2023.